Aktas O - Search Results

1

Acetazolamide therapy in a case of fingolimod-associated macular edema: early benefits and long-term limitations.

Schröder K, Finis D, Harmel J, Ringelstein M, Hartung HP, Geerling G, Aktas O, Guthoff R. Schröder K, et al. Among authors: aktas o. Mult Scler Relat Disord. 2015 Sep;4(5):406-408. doi: 10.1016/j.msard.2015.06.015. Epub 2015 Jul 2. Mult Scler Relat Disord. 2015. PMID: 26346788

2

Impact of HMG-CoA reductase inhibition on brain pathology.

Zipp F, Waiczies S, Aktas O, Neuhaus O, Hemmer B, Schraven B, Nitsch R, Hartung HP. Zipp F, et al. Among authors: aktas o. Trends Pharmacol Sci. 2007 Jul;28(7):342-9. doi: 10.1016/j.tips.2007.05.001. Epub 2007 Jun 15. Trends Pharmacol Sci. 2007. PMID: 17573124 Review.

3

Neuromyelitis and more: the unfolding spectrum of aquaporin 4-related neurological diseases.

Aktas O, Hartung HP. Aktas O, et al. J Neurol. 2009 Nov;256(11):1906-8. doi: 10.1007/s00415-009-5317-x. J Neurol. 2009. PMID: 19768482 No abstract available.

4

Bleak prospects for primary progressive multiple sclerosis therapy: downs and downs, but a glimmer of hope.

Hartung HP, Aktas O. Hartung HP, et al. Among authors: aktas o. Ann Neurol. 2009 Oct;66(4):429-32. doi: 10.1002/ana.21880. Ann Neurol. 2009. PMID: 19847907 No abstract available.

5

Development of oral cladribine for the treatment of multiple sclerosis.

Hartung HP, Aktas O, Kieseier B, Giancarlo Comi GC. Hartung HP, et al. Among authors: aktas o. J Neurol. 2010 Feb;257(2):163-70. doi: 10.1007/s00415-009-5359-0. J Neurol. 2010. PMID: 19921304 Review.

6

Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis.

Aktas O, Kieseier B, Hartung HP. Aktas O, et al. Trends Neurosci. 2010 Mar;33(3):140-52. doi: 10.1016/j.tins.2009.12.002. Epub 2010 Jan 4. Trends Neurosci. 2010. PMID: 20045200 Review.

7

Oral therapies for multiple sclerosis: are we there yet?

Hartung HP, Aktas O. Hartung HP, et al. Among authors: aktas o. Lancet Neurol. 2010 May;9(5):454-7. doi: 10.1016/S1474-4422(10)70088-0. Lancet Neurol. 2010. PMID: 20398852 No abstract available.

8

Fingolimod is a potential novel therapy for multiple sclerosis.

Aktas O, Küry P, Kieseier B, Hartung HP. Aktas O, et al. Nat Rev Neurol. 2010 Jul;6(7):373-82. doi: 10.1038/nrneurol.2010.76. Epub 2010 Jun 15. Nat Rev Neurol. 2010. PMID: 20551946 Review.

9

Evolution of multiple sclerosis treatment: next generation therapies meet next generation efficacy criteria.

Hartung HP, Aktas O. Hartung HP, et al. Among authors: aktas o. Lancet Neurol. 2011 Apr;10(4):293-5. doi: 10.1016/S1474-4422(11)70043-6. Lancet Neurol. 2011. PMID: 21397566 No abstract available.

10

Beyond axonal transection: hippocampal damage in multiple sclerosis.

Aktas O, Hartung HP. Aktas O, et al. Ann Neurol. 2011 Mar;69(3):433-6. doi: 10.1002/ana.22409. Ann Neurol. 2011. PMID: 21446019 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

427 results

Search Page

Filters